Insider filing · CRNX
Stephen F. Betz
Chief Scientific Officer
profile →
Crinetics Pharmaceuticals, Inc.
CRNX · Healthcare · 30 filings in 24 months
ticker →
Stephen F. Betz sold $3.1M of Crinetics Pharmaceuticals (CRNX)
Executed Jun 12 2025, disclosed Jun 16 2025, 4 days later.
Value, as filed
$3.1M
97,483 sh × $32.23
Executed
Jun 12 2025
the trade date, as filed
Disclosed
Jun 16 2025
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
SBStephen F. Betz (Chief Scientific Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Crinetics Pharmaceuticals, Inc. (CRNX). The largest single filing was $397K of CRNX (10,612 sh across 2 lots, as filed), executed Mar 16.
The name
CRNXHealthcare · Crinetics Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of n…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Stephen F. Betz in CRNX
CRNXSALE
Crinetics Pharmaceuticals, Inc.
$397K10,612 sh across 2 lots
Exec Mar 16
Filed Mar 18 · 5:30 PM ET CRNXSALE Crinetics Pharmaceuticals, Inc. $187K
5,479 sh × $34.17
Exec Mar 19 2025
Filed Mar 21 2025 · 5:30 PM ET